Growing Diabetes Prevalence Fueling Insulin Delivery Device Sales

The rising incidence of diabetes, on account of the growing prevalence of obesity, is pushing up the demand for insulin delivery devices. As per the World Health Organization (WHO), nearly 2.8 million deaths are recorded every year because of obesity and around 44% of the diabetes cases across the world are caused because of excess weight or obesity. Furthermore, the organization reported that the incidence of obesity increased nearly three-fold between 1975 and 2016.

Additionally, around 13% of the global adult population (15% of women and 11% of men) was obese in 2016, and over 1.9 billion adults in the age bracket- 18 years and older- were overweight in 2016. Out of these, more than 650 million adults were obese. As obesity makes a person highly vulnerable to diabetes, its growing incidence is propelling the demand for insulin delivery devices. Diabetic people don’t have a stable blood glucose level and thus, need insulin therapy.

The therapy is used for managing both type 1 and type 2 diabetes. Besides, the surging geriatric population in several countries is also driving the worldwide demand for insulin delivery devices, as geriatric people are highly susceptible to diabetes. This is, in turn, fueling the growth of the global insulin delivery device market. According to the forecast of the market research company, P&S Intelligence, the market will advance at a CAGR of 6.6% between 2016 and 2022.

Pumps, syringes, and pens are the most widely used types of insulin delivery devices across the world. Out of these, the demand for pumps is predicted to surge sharply in the coming years. Geographically, the sales of insulin delivery devices were observed to be the highest in North America in the years gone by. Europe recorded the second-highest sales of these devices across the globe during the last few years.